Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

5.2K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A European collaborative initiative to systematically map cancer risk by migration background: the Cancer RADAR project.

International journal for equity in health·2026
Same author

Population-Based First Estimates of the Effect of HPV Vaccination in Three Italian Areas Covered by Organised Cervical Screening.

International journal of cancer·2026
Same author

From evidence to action: the IARC's role in strengthening cancer prevention and early detection.

Journal of the National Cancer Institute. Monographs·2026
Same author

Oncogenic infections: targets highly amenable to cancer prevention.

Journal of the National Cancer Institute. Monographs·2026
Same author

Systematic review and meta-analysis of cervico-vaginal high-risk human papillomavirus prevalence in India prior to nationwide human papillomavirus vaccination.

Archives of public health = Archives belges de sante publique·2026
Same author

Correction to "Predicting cohort-specific cervical cancer incidence from population-based surveys of human papilloma virus prevalence: a worldwide study".

American journal of epidemiology·2026
Same journal

Modeling and analysis of forward and inverse kinematics for a flexible Stewart platform.

PloS one·2026
Same journal

Barriers and facilitators to healthcare utilization amongst people living with sickle cell disease in the United States: A scoping review.

PloS one·2026
Same journal

Enhancing data completeness in time series: Imputation strategies for missing data using significant periodically correlated components.

PloS one·2026
Same journal

Key targets and mechanisms by which gut microbiota-derived metabolites regulate Alzheimer's disease through the immune - inflammatory pathway: Based on network pharmacology and molecular docking.

PloS one·2026
Same journal

Grid-tied Transformer-less Boost Switched Capacitor Topology (TLBSCT) for PV applications.

PloS one·2026
Same journal

The load-velocity profiles and exercise-specific velocity zones for seven commonly used weightlifting exercises.

PloS one·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

11.4K

Type-specific human papillomavirus biological features: validated model-based estimates.

Iacopo Baussano1, K Miriam Elfström2, Fulvio Lazzarato3

  • 1International Agency for Research on Cancer, Lyon, France.

Plos One
|January 9, 2014
PubMed
Summary
This summary is machine-generated.

Mathematical models estimate high-risk human papillomavirus (HPV) transmission and clearance rates. These findings are crucial for predicting the global impact of HPV vaccination programs on cervical cancer prevention.

More Related Videos

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
13:56

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

10.6K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.9K

Related Experiment Videos

Last Updated: May 4, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

11.4K
A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
13:56

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

10.6K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.9K

Area of Science:

  • Epidemiology
  • Mathematical Modeling
  • Public Health

Background:

  • High-risk human papillomavirus (hrHPV) infection is essential for cervical cancer development.
  • Vaccination against HPV types 16 and 18, responsible for ~75% of cervical cancers, is key for global cervical cancer reduction.
  • Accurate natural history parameters of hrHPV infections are vital for reliable vaccination impact projections.

Purpose of the Study:

  • To develop and validate a mathematical model estimating key parameters of hrHPV infection natural history.
  • To assess the consistency of model estimates across two distinct unvaccinated populations (Italy and Sweden).

Main Methods:

  • A mathematical model was developed to estimate hrHPV transmission probability, clearance rates, and immune response patterns for 13 hrHPV types.
  • The model was fitted to independent datasets from Italy and Sweden, accounting for differences in sexual behavior, age distribution, and study settings.
  • Model validity was tested by its ability to predict HPV16 prevalence in a specific Italian cohort.

Main Results:

  • Estimated hrHPV transmission probabilities were high (e.g., 80% for HPV16, 73%-82% for HPV18).
  • Clearance rates decreased over time post-infection, and partial protection against reinfection was observed (approx. 20% for HPV16, 50% for others).
  • Model estimates for transmission, clearance, and partial immunity were consistent across both countries.

Conclusions:

  • The developed mathematical model provides essential biological parameters for hrHPV infection natural history, which are not directly measurable empirically.
  • These model-derived parameters are crucial for forecasting the future impact of HPV vaccination programs on cervical cancer.
  • The consistency of findings across diverse populations supports the generalizability of the model's estimates.